Kalvista Pharmaceuticals Inc. (KALV)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1. 3,440,345 $42,144,226 3.89%
2. 2,684,005 $32,879,061 +11% 1.48%
3.
Leucadia National

Ian Cumming And Joseph Steinberg

1,080,000 $13,230,000 +5% 0.08%
4.
Driehaus Capital

Richard Driehaus

1,028,568 $12,599,958 -1% 0.15%
5.
Vivo Capital

Albert Cha And Frank Kung

856,008 $10,486,098 0.85%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$14.70 29,747 4,824,731 2024-02-08 Filing
$14.56 51,827 4,794,984 2024-02-07 Filing
$14.74 4,474 4,743,157 2024-02-06 Filing
$14.47 88,099 4,738,683 2024-01-30 Filing
$14.22 80,600 4,650,584 2024-01-29 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$14.72 300 62,157 2024-02-20 Filing
$14.04 19,591 62,457 2024-02-20 Filing
$14.11 8,397 82,048 2024-02-20 Filing
$14.11 12,053 72,895 2024-02-20 Filing
$14.11 22,802 187,315 2024-02-20 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 4,092,731 $50,135,955 3.43%
2. 3,622,294 $44,373,102 2.37%
3. 3,395,495 $41,594,814 4.61%
4. 2,242,025 $27,464,808 0%
5. 1,807,563 $22,142,647 8.47%
News See All